EGFR and lung carcinoma: To gain insight into the molecular mechanisms of EGFR-TKI resistance, we compared the expression profile of lncRNAs between gefitinib-sensitive and gefitinib-resistant human lung cancer cells by lncRNA microarray and found that thousands of lncRNAs were up-regulated in gefitinib-resistant cells [16].